These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34672343)

  • 1. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
    van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
    BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 3. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
    Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
    Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
    Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
    Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
    Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
    Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
    Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
    Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    van Ham NCM; Glazemakers S; van der Ende-van Loon M; Nieuwenhuijzen GAP; Rutten HJT; Tolenaar JL; Jacobs A; Burger JWA; Ketelaers SHJ; Bloemen JG
    Eur J Surg Oncol; 2024 Jun; 50(6):108259. PubMed ID: 38552415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Westberg K; Palmer G; Hjern F; Holm T; Martling A
    Br J Surg; 2019 May; 106(6):790-798. PubMed ID: 30776087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of flap reconstruction on perineal wound complications following ablative surgery for advanced and recurrent rectal cancers.
    Davidge KM; Raghuram K; Hofer SO; Ferguson PC; Wunder JS; Swallow CJ; Zhong T
    Ann Surg Oncol; 2014 Jun; 21(6):2068-73. PubMed ID: 24522990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
    Khan O; Patsouras D; Ravindraanandan M; Abrar MM; Schizas A; George M; Malde S; Thurairaja R; Khan MS; Sahai A
    Eur Urol Focus; 2021 May; 7(3):638-643. PubMed ID: 32622667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
    Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
    Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
    Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
    Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
    Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
    Aiba T; Uehara K; Tsuyuki Y; Ogura A; Murata Y; Mizuno T; Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T
    Eur J Surg Oncol; 2022 Dec; 48(12):2502-2508. PubMed ID: 35768314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.